Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

368
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
368
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

336
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
336
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

33
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
33
Biostatistics: Overview01:20

Biostatistics: Overview

227
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
227
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing semantic interoperability in precision medicine: converting OMOP CDM to Beacon v2 in the Spanish IMPaCT-Data project.

BMC medical informatics and decision making·2026
Same author

Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosis.

ERJ open research·2026
Same author

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same author

BRCA1 c.68_69del as a founder variant in the Spanish Roma: prevalence and screening implications.

European journal of human genetics : EJHG·2026
Same author

PolyGenie: a reproducible Nextflow pipeline for phenome-wide association studies using polygenic risk scores.

NAR genomics and bioinformatics·2026
Same author

Feasibility of the Xemio app for breast cancer survivors in a clinical setting: Adherence, acceptance, and side effect monitoring (CTCAE vs. QoL).

PloS one·2026

Related Experiment Video

Updated: Jun 15, 2025

Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations
11:36

Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations

Published on: April 21, 2023

2.0K

DATOS-CAT: OMOP-Common Data Model for the Standardization, Integration and Analysis of Population-Based Biomedical

Aikaterini Lymperidou1,2, Judith Martinez-Gonzalez1,3, Guillem Bracons Cucó1,4

  • 1Institute for Bioengineering of Catalonia, Barcelona, Spain.

Studies in Health Technology and Informatics
|August 23, 2024
PubMed
Summary

Transforming biomedical data into the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) allows researchers to study genetic profiles and clinical outcomes. This enhances understanding and influences global healthcare practices.

Keywords:
DATOS-CATFAIR principlesGCATOMOP-CDM

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K

Related Experiment Videos

Last Updated: Jun 15, 2025

Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations
11:36

Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations

Published on: April 21, 2023

2.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K

Area of Science:

  • Biomedical Informatics
  • Genetics
  • Health Outcomes Research

Background:

  • Biomedical cohort data often exists in disparate formats, hindering large-scale analysis.
  • Standardization is crucial for integrating diverse datasets and enabling comparative research.

Purpose of the Study:

  • To describe the transformation of a population-based biomedical cohort into the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM).
  • To highlight the utility of the OMOP-CDM for investigating the relationship between genetic profiles and clinical outcomes.

Main Methods:

  • Population-based cohort data was mapped to the OMOP-CDM structure.
  • Standardized data elements facilitated the integration of genetic and clinical information.

Main Results:

  • The OMOP-CDM enabled direct access to integrated population-based data.
  • Facilitated the exploration of genotype-phenotype relationships within the cohort.

Conclusions:

  • The OMOP-CDM is a valuable framework for transforming biomedical cohort data.
  • This approach advances the understanding of genetic influences on health and can impact global healthcare.
  • Enables new knowledge discovery for improved clinical practices worldwide.